Detalhe da pesquisa
1.
A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas.
Blood
; 138(26): 2828-2837, 2021 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34653242
2.
Anaphylaxis to horses and epinephrine use: Increasing awareness among pediatric patients and families.
Pediatr Allergy Immunol
; 28(6): 608-610, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28686311
3.
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.
J Clin Oncol
; 39(28): 3109-3117, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34170745
4.
Pediatric Hispanic versus non-Hispanic patients with partial DiGeorge syndrome.
J Allergy Clin Immunol Pract
; 8(1): 383-384, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31253579
5.
Subcutaneous immunoglobulin replacement therapy: ensuring success.
J Infus Nurs
; 38(1): 70-9, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25545976
6.
Nursing guidelines for administration of immunoglobulin replacement therapy.
J Infus Nurs
; 36(1): 58-68, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23271153